ES2303507T3 - Metodos para purificacion de proteinas recombinantes antagonistas de la hormona del crecimiento utilizando extraccion acuosa en dos fases. - Google Patents
Metodos para purificacion de proteinas recombinantes antagonistas de la hormona del crecimiento utilizando extraccion acuosa en dos fases. Download PDFInfo
- Publication number
- ES2303507T3 ES2303507T3 ES00928866T ES00928866T ES2303507T3 ES 2303507 T3 ES2303507 T3 ES 2303507T3 ES 00928866 T ES00928866 T ES 00928866T ES 00928866 T ES00928866 T ES 00928866T ES 2303507 T3 ES2303507 T3 ES 2303507T3
- Authority
- ES
- Spain
- Prior art keywords
- phases
- purification
- growth hormone
- methods
- recombinant proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un método para purificación de proteínas recombinantes antagonistas de la hormona del crecimiento ("rHGA"), que comprende (a) añadir un primer y un segundo agente formador de fase a una muestra que contiene rGHA, en donde dichos agentes primero y segundo formadores de fase pueden añadirse en cualquier orden; (b) mezclar la muestra del paso (a); (c) separar la muestra del paso (b) en dos fases; en donde no se añade a la muestra agente caotrópico alguno; en donde el primer agente formador de fase es sulfato de amonio; en donde el segundo agente formador de fase es PEG 4600.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/307,549 US6437101B1 (en) | 1999-05-07 | 1999-05-07 | Methods for protein purification using aqueous two-phase extraction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2303507T3 true ES2303507T3 (es) | 2008-08-16 |
Family
ID=23190235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00928866T Expired - Lifetime ES2303507T3 (es) | 1999-05-07 | 2000-05-04 | Metodos para purificacion de proteinas recombinantes antagonistas de la hormona del crecimiento utilizando extraccion acuosa en dos fases. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6437101B1 (es) |
| EP (1) | EP1194445B1 (es) |
| JP (1) | JP2002544139A (es) |
| AT (1) | ATE384737T1 (es) |
| AU (1) | AU777974B2 (es) |
| BR (1) | BR0010707A (es) |
| CA (1) | CA2372513A1 (es) |
| DE (1) | DE60037886T2 (es) |
| ES (1) | ES2303507T3 (es) |
| IL (1) | IL146381A0 (es) |
| MX (1) | MXPA01011356A (es) |
| NZ (1) | NZ515381A (es) |
| WO (1) | WO2000068260A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6966992B2 (en) * | 2001-03-19 | 2005-11-22 | Akzo Nobel Nv | Method of purification of molecules using unbranched terminal alkyldiols |
| US20060128615A1 (en) * | 2002-09-18 | 2006-06-15 | Pierrette Gaudreau | Ghrh analogues |
| EP1609800B1 (de) * | 2004-06-25 | 2007-11-14 | Kühni Ag | Verfahren zur Extraktion von biologischem Material |
| AU2005259269B2 (en) * | 2004-06-29 | 2010-12-09 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
| US20070048786A1 (en) * | 2005-09-01 | 2007-03-01 | Arnon Chait | Systems and methods for fractionation of protein mixtures |
| US20080070230A1 (en) * | 2006-06-12 | 2008-03-20 | Wyeth | Methods for reducing or preventing liquid-liquid phase separation in high concentration protein solutions |
| KR100836171B1 (ko) | 2007-01-19 | 2008-06-09 | 인하대학교 산학협력단 | 분배 향상 물질이 접합된 생물물질을 이용한 수성이상계추출법에서의 친화성 분리 방법 |
| DE102008013490A1 (de) * | 2008-03-10 | 2009-09-17 | Bayer Technology Services Gmbh | Verfahren zur Reinigung therapeutischer Proteine |
| EP2350113A4 (en) * | 2008-11-25 | 2013-01-02 | Ge Healthcare Bio Sciences Ab | FOR AN AQUEOUS TWO-PHASE EXTRACTION REINFORCED DEPOSITION PROCESS FOR CLEANING THERAPEUTIC PROTEINS |
| DE102011001743A1 (de) * | 2011-04-01 | 2012-10-04 | Technische Universität Dortmund | Verfahren zur Trennung/Reinigung von Biomolekühlen |
| CN102662015B (zh) * | 2012-04-12 | 2013-11-20 | 湖南师范大学 | 基于无机盐促相变分离纳米金的生物样品的净化方法 |
| US20130310554A1 (en) * | 2012-05-18 | 2013-11-21 | Hong Kong Baptist University | Aqueous Diphase Solvent System for Preparing High-Purity Polysaccharides |
| CN111249531B (zh) * | 2020-01-19 | 2022-03-22 | 巴斯特医药科技(常州)有限公司 | 一种高活性植物酶制备胶原蛋白支架的方法 |
| CN114957494A (zh) * | 2021-02-23 | 2022-08-30 | 江苏农牧科技职业学院 | 一种采用双水相萃取黄精多糖中蛋白质的工艺 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK144731C (da) | 1976-07-30 | 1982-10-18 | Nordisk Insulinlab | Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev |
| JPS5815989A (ja) * | 1981-06-12 | 1983-01-29 | Sanki Eng Kk | 生理活性蛋白質の精製方法 |
| DE3908422A1 (de) * | 1989-03-15 | 1990-09-20 | Forschungszentrum Juelich Gmbh | Verfahren zur extraktion von proteinen aus waessrigen biomassesuspensionen |
| US5139943A (en) * | 1989-06-13 | 1992-08-18 | Genencor International, Inc. | Processes for the recovery of microbially produced chymosin |
| US5151358A (en) | 1989-06-13 | 1992-09-29 | Genencor International, Inc. | Processes for the recovery of naturally produced chymosin |
| US5182369A (en) | 1990-02-28 | 1993-01-26 | Monsanto Company | Method for purifying somatotropin monomers |
| US5328841A (en) * | 1990-10-05 | 1994-07-12 | Genencor International, Inc. | Methods for isolating EG III cellulase component and EG III cellulase in polyethylene glycol using inorganic salt and polyethylene glycol |
| SE9003534D0 (sv) * | 1990-11-06 | 1990-11-06 | Kabigen Ab | A method for isolating and purifying peptides and proteins |
| US5407810A (en) | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
| US5734024A (en) * | 1996-04-19 | 1998-03-31 | Boris Y. Zaslavsky | Method for determining the biological activity of recombinant human growth hormone |
| GB0205898D0 (en) * | 2002-03-13 | 2002-04-24 | Pharmacia Ab | Treatment of type I diabetes mellitus |
-
1999
- 1999-05-07 US US09/307,549 patent/US6437101B1/en not_active Expired - Lifetime
-
2000
- 2000-05-04 AT AT00928866T patent/ATE384737T1/de not_active IP Right Cessation
- 2000-05-04 BR BR0010707-7A patent/BR0010707A/pt not_active IP Right Cessation
- 2000-05-04 DE DE60037886T patent/DE60037886T2/de not_active Expired - Fee Related
- 2000-05-04 EP EP00928866A patent/EP1194445B1/en not_active Expired - Lifetime
- 2000-05-04 IL IL14638100A patent/IL146381A0/xx unknown
- 2000-05-04 MX MXPA01011356A patent/MXPA01011356A/es active IP Right Grant
- 2000-05-04 JP JP2000616234A patent/JP2002544139A/ja not_active Withdrawn
- 2000-05-04 CA CA002372513A patent/CA2372513A1/en not_active Abandoned
- 2000-05-04 NZ NZ515381A patent/NZ515381A/en unknown
- 2000-05-04 AU AU47036/00A patent/AU777974B2/en not_active Ceased
- 2000-05-04 ES ES00928866T patent/ES2303507T3/es not_active Expired - Lifetime
- 2000-05-04 WO PCT/US2000/012320 patent/WO2000068260A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000068260A1 (en) | 2000-11-16 |
| NZ515381A (en) | 2003-10-31 |
| BR0010707A (pt) | 2002-06-04 |
| MXPA01011356A (es) | 2003-08-20 |
| AU4703600A (en) | 2000-11-21 |
| IL146381A0 (en) | 2002-07-25 |
| EP1194445A1 (en) | 2002-04-10 |
| EP1194445A4 (en) | 2002-10-09 |
| CA2372513A1 (en) | 2000-11-16 |
| ATE384737T1 (de) | 2008-02-15 |
| US6437101B1 (en) | 2002-08-20 |
| EP1194445B1 (en) | 2008-01-23 |
| JP2002544139A (ja) | 2002-12-24 |
| DE60037886T2 (de) | 2009-01-22 |
| AU777974B2 (en) | 2004-11-04 |
| DE60037886D1 (de) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sap et al. | The c-erb-A protein is a high-affinity receptor for thyroid hormone | |
| BR0311877A (pt) | Preparações ácidas de insulina com estabilidade aperfeiçoada | |
| EP1049459A4 (en) | ORAL LIQUID COMPOSITIONS | |
| AR018526A1 (es) | COMPOSICION FARMACEUTICA NO LIOFILIZADA EN FORMA DE SOLUCIoN QUE COMPRENDE LA HORMONA PARATIROIDEA HUMANA, PROCESO PARA PREPARA UN FRASCO O CARTUCHO QUE LA CONTIENE, PROCESO PARA PREPARAR DICHA COMPOSICIoN, FRASCO O CARTUCHO QUE CONTIENE LA COMPOSICIoN Y USO DE LA MISMA PARA LA FABRICACIoN DE UN MED | |
| BR0108959A (pt) | Composições de poloxmero ou poloxamina melhoradas para distribuição de ácido nucléico | |
| NO992068D0 (no) | Mikroemulsjon og fremgangsmÕte for fremstilling av denne | |
| BR0009678A (pt) | Compostos, composição farmacêutica, e, uso de compostos | |
| WO2003012050A3 (en) | Mitochondrial genome replenishment | |
| AR035786A2 (es) | Variantes de factores de coagulacion dependientes de vitamina k y composiciones que los contienen | |
| BR0106100A (pt) | Composição de gesso fixado, artigo, e, método para preparar uma composição de gesso fixado | |
| DE60144145D1 (de) | Subtilisin-variante | |
| DE60203692D1 (de) | Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen | |
| Cohen et al. | Effect of extradiol-17beta on the synthesis of specific uterine nonhistone chromosomal proteins. | |
| EP0293158A2 (en) | Parathyroid hormone antagonists | |
| DE69119656D1 (de) | Satz zur spezifischen Bestimmung von Angiotensin-II | |
| Tonna | Periosteal osteoclasts, skeletal development and ageing | |
| BR0008341A (pt) | Sol orgânico, composto sólido, processo de preração de um sol, e, utilização de um sol | |
| TR199801104T2 (xx) | Ereksiyon disfonksiyonunun tedavisinde kullan�lan PGE-1 i�eren liyofilize lipozomlar. | |
| DE69122267D1 (de) | Verfahren zum beimischen von zuschlagstoffen in eine versprühte betonmasse und wirkstoff zur anwendung des verfahrens | |
| ATA17485A (de) | Verfahren zur dosierten abgabe von mischfutter, insbesondere fluessig-mischfutter | |
| AR021990A1 (es) | Auxiliar detergente liquido acuoso multifase, procedimiento para su elaboracion, empleo y articulo que lo contiene | |
| Liang et al. | Specific binding of an immunoreactive and biologically active 125I-labeled N (1) acylated substance P derivative to parotid cells | |
| ES2170144T3 (es) | Variantes que no se empalman de gp350/220. | |
| ES2302374T3 (es) | Compuesto selectivo de receptores pth2. | |
| DE60003057D1 (de) | Verfahren zur extraktion mit einem überkritischen fluid |